CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,397,150 | -16.6% | 30,781 | +3.1% | 0.14% | -17.5% |
| Q2 2023 | $1,676,116 | +26.2% | 29,856 | +1.6% | 0.17% | +5.7% |
| Q1 2023 | $1,328,541 | +19.9% | 29,373 | +7.7% | 0.16% | +18.9% |
| Q4 2022 | $1,108,322 | -42.2% | 27,265 | -7.0% | 0.13% | -46.8% |
| Q3 2022 | $1,916,000 | +11.7% | 29,321 | +3.9% | 0.25% | +19.2% |
| Q2 2022 | $1,715,000 | +1.2% | 28,229 | +4.6% | 0.21% | +13.0% |
| Q1 2022 | $1,694,000 | +9.6% | 26,987 | +32.3% | 0.18% | +0.5% |
| Q4 2021 | $1,546,000 | -37.5% | 20,396 | -7.6% | 0.18% | -41.3% |
| Q3 2021 | $2,472,000 | -32.5% | 22,084 | -2.3% | 0.31% | -32.2% |
| Q2 2021 | $3,661,000 | +44.8% | 22,613 | +9.0% | 0.46% | +28.9% |
| Q1 2021 | $2,529,000 | -1.3% | 20,755 | +24.1% | 0.36% | -6.1% |
| Q4 2020 | $2,562,000 | +38.9% | 16,730 | -24.2% | 0.38% | +9.5% |
| Q3 2020 | $1,845,000 | -6.4% | 22,062 | -17.8% | 0.35% | -13.0% |
| Q2 2020 | $1,972,000 | +90.2% | 26,837 | +9.8% | 0.40% | +57.7% |
| Q1 2020 | $1,037,000 | -27.6% | 24,443 | +4.0% | 0.25% | -33.9% |
| Q4 2019 | $1,432,000 | +48.2% | 23,508 | -0.3% | 0.38% | +42.4% |
| Q3 2019 | $966,000 | -19.4% | 23,573 | -2.9% | 0.27% | -26.3% |
| Q2 2019 | $1,199,000 | +46.9% | 24,268 | +6.2% | 0.36% | +20.1% |
| Q1 2019 | $816,000 | +13.0% | 22,854 | -9.6% | 0.30% | -1.3% |
| Q4 2018 | $722,000 | -3.7% | 25,279 | +49.6% | 0.31% | -12.3% |
| Q3 2018 | $750,000 | -29.0% | 16,903 | -5.9% | 0.35% | -33.5% |
| Q2 2018 | $1,056,000 | +63.2% | 17,963 | +26.9% | 0.53% | +46.3% |
| Q1 2018 | $647,000 | +167.4% | 14,160 | +37.5% | 0.36% | +154.2% |
| Q4 2017 | $242,000 | +25.4% | 10,300 | -4.6% | 0.14% | +19.3% |
| Q3 2017 | $193,000 | – | 10,800 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |